Literature DB >> 12117403

Failure of estrogen plus progestin therapy for prevention.

Suzanne W Fletcher, Graham A Colditz.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12117403     DOI： 10.1001/jama.288.3.366

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  26 in total

1.  Message about hormone replacement therapy is unclear.

Authors:  J Michael Dixon
Journal:  BMJ       Date:  2002-11-02

Review 2.  Postmenopausal hormone replacement therapy and atherosclerosis.

Authors:  Jennifer E Ho; Lori Mosca
Journal:  Curr Atheroscler Rep       Date:  2002-09       Impact factor: 5.113

Review 3.  Making decisions about hormone replacement therapy.

Authors:  Janice Rymer; Ruth Wilson; Karen Ballard
Journal:  BMJ       Date:  2003-02-08

4.  Hormone replacement therapy. Logically, long term hormone replacement therapy cannot be recommended.

Authors:  Kishore Shetty
Journal:  BMJ       Date:  2002-11-23

Review 5.  Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.

Authors:  Martin Hersberger; Arnold von Eckardstein
Journal:  Drugs       Date:  2003       Impact factor: 9.546

6.  [Evidence based basis of decision making for or against a postmenopausal hormone treatment].

Authors:  Eva Rásky
Journal:  Wien Klin Wochenschr       Date:  2004-07-31       Impact factor: 1.704

7.  Facts and ideas from anywhere.

Authors:  William Clifford Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2002-10

8.  Health status of users of hormone replacement therapy by hysterectomy status in Western Australia.

Authors:  L J Lambert; J A Y Straton; M W Knuiman; H C Bartholomew
Journal:  J Epidemiol Community Health       Date:  2003-04       Impact factor: 3.710

9.  Validation of a decision model for preventive pharmacological strategies in postmenopausal women.

Authors:  Sylvie Perreault; Carey Levinton; Claudine Laurier; Yola Moride; Louis-Georges Ste-Marie; Ralph Crott
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

10.  Estradiol and dehydroepiandrosterone potentiate levodopa-induced locomotor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.

Authors:  Nancy Bélanger; Laurent Grégoire; Paul Bédard; Thérèse Di Paolo
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.